AI filing briefs · archive

8-K filings in April 2013, explained

2 material Form 8-K filings that 1 company we cover made with the SEC in April 2013, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

2 briefs

newest first · times in ET
NEGGNewegg Commerce, Inc. Apr 26, 5:02 PM ET

Newegg Commerce says it is now a foreign private issuer, will file 20-F and 6-K reports

Neutral other Written later 8.01

Newegg Commerce disclosed that on April 23, 2013 it determined it qualifies as a foreign private issuer under Exchange Act Rule 3b-4, and it will begin reporting as one effective immediately after this filing. The filing says it will file annual reports on Form 20-F and current reports on Form 6-K. The signature block names Dehaier Medical Systems Limited and Ping Chen as CEO, which does not match the Newegg name in the filing details, so the registrant's identity should be confirmed. The change affects reporting obligations and does not include any financial results.

  • Determination date: April 23, 2013
  • Status effective immediately after the filing of this Form 8-K
  • Future reports: annual report on Form 20-F and current reports on Form 6-K
  • Signature block names Dehaier Medical Systems Limited and CEO Ping Chen, which differs from the Newegg name in the filing details
Read the filing on SEC.gov ↗
NEGGNewegg Commerce, Inc. Apr 3, 9:45 PM ET

Dehaier Medical: CFO Charles Li joins board; director Weibing Yang resigns

Neutral leadership Written later 5.02

Dehaier Medical Systems Limited said its chief financial officer, Charles Li, was appointed to its board effective March 30, 2013, and director Weibing Yang resigned the same day. The filing states Yang's resignation was not due to any disagreement with the company, and Li will receive no extra pay for board service. The filing names Dehaier Medical Systems Limited, not Newegg Commerce, so this summary covers the Dehaier filing.

  • Charles Li, 27, appointed to the board effective March 30, 2013, as a Class II member until the 2015 shareholder meeting
  • Li is also chief financial officer and will receive no director compensation beyond his CFO pay
  • Weibing Yang resigned as a director effective March 30, 2013; the filing says there was no disagreement
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.